Tasly Pharmaceutical Group Co., Ltd (600535.SS)
CNY 15.25
(1.19%)
CNY 15.25
(1.19%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.56 Billion CNY | -2.1% |
| 2022 | 4.12 Billion CNY | 4.23% |
| 2021 | 3.96 Billion CNY | -0.61% |
| 2020 | 3.98 Billion CNY | 0.97% |
| 2019 | 3.94 Billion CNY | -2.8% |
| 2018 | 4.06 Billion CNY | 10.79% |
| 2017 | 3.66 Billion CNY | 8.41% |
| 2016 | 3.38 Billion CNY | 10.13% |
| 2015 | 3.07 Billion CNY | 12.25% |
| 2014 | 2.73 Billion CNY | 11.12% |
| 2013 | 2.46 Billion CNY | 42.02% |
| 2012 | 1.73 Billion CNY | 42.02% |
| 2011 | 1.22 Billion CNY | 26.09% |
| 2010 | 968.28 Million CNY | 10.93% |
| 2009 | 872.88 Million CNY | 16.52% |
| 2008 | 749.11 Million CNY | 14.56% |
| 2007 | 653.89 Million CNY | 20.39% |
| 2006 | 543.15 Million CNY | 5.44% |
| 2005 | 515.11 Million CNY | -6.73% |
| 2004 | 552.27 Million CNY | -4.92% |
| 2003 | 580.85 Million CNY | 1.97% |
| 2002 | 569.64 Million CNY | 45.85% |
| 2001 | 390.57 Million CNY | 85.72% |
| 2000 | 210.29 Million CNY | 61.04% |
| 1999 | 130.58 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 1.04 Billion CNY | 18.59% |
| 2024 Q1 | 967.24 Million CNY | -18.67% |
| 2024 Q2 | 981.04 Million CNY | 1.43% |
| 2023 Q3 | 1.04 Billion CNY | -2.67% |
| 2023 Q1 | 940.06 Million CNY | -19.22% |
| 2023 Q2 | 1.07 Billion CNY | 14.32% |
| 2023 FY | 4.04 Billion CNY | -2.1% |
| 2023 Q4 | 1.18 Billion CNY | 13.7% |
| 2022 Q2 | 1.11 Billion CNY | 31.39% |
| 2022 FY | 4.12 Billion CNY | 4.23% |
| 2022 Q4 | 1.16 Billion CNY | 16.09% |
| 2022 Q3 | 1 Billion CNY | -10.1% |
| 2022 Q1 | 848.72 Million CNY | -35.95% |
| 2021 Q3 | 918.49 Million CNY | 1.25% |
| 2021 Q2 | 907.18 Million CNY | 11.79% |
| 2021 Q1 | 811.48 Million CNY | -50.96% |
| 2021 FY | 3.96 Billion CNY | -0.61% |
| 2021 Q4 | 1.32 Billion CNY | 44.27% |
| 2020 Q1 | 699.9 Million CNY | -47.16% |
| 2020 Q3 | 790.67 Million CNY | -6.01% |
| 2020 Q4 | 1.65 Billion CNY | 109.3% |
| 2020 Q2 | 841.25 Million CNY | 20.19% |
| 2020 FY | 3.98 Billion CNY | 0.97% |
| 2019 FY | 3.94 Billion CNY | -2.8% |
| 2019 Q3 | 875.94 Million CNY | -3.79% |
| 2019 Q4 | 1.32 Billion CNY | 51.22% |
| 2019 Q1 | 837.57 Million CNY | -42.64% |
| 2019 Q2 | 910.47 Million CNY | 8.7% |
| 2018 Q4 | 1.46 Billion CNY | 52.01% |
| 2018 FY | 4.06 Billion CNY | 10.79% |
| 2018 Q3 | 960.56 Million CNY | 12.19% |
| 2018 Q2 | 856.18 Million CNY | 8.98% |
| 2018 Q1 | 785.61 Million CNY | -49.38% |
| 2017 Q4 | 1.55 Billion CNY | 92.05% |
| 2017 FY | 3.66 Billion CNY | 8.41% |
| 2017 Q3 | 808.2 Million CNY | 16.21% |
| 2017 Q1 | 611.03 Million CNY | -60.5% |
| 2017 Q2 | 695.49 Million CNY | 13.82% |
| 2016 Q1 | 567.62 Million CNY | -47.34% |
| 2016 FY | 3.38 Billion CNY | 10.13% |
| 2016 Q4 | 1.54 Billion CNY | 157.38% |
| 2016 Q3 | 601.02 Million CNY | -9.88% |
| 2016 Q2 | 666.89 Million CNY | 17.49% |
| 2015 Q4 | 1.07 Billion CNY | 63.84% |
| 2015 Q1 | 746.3 Million CNY | -20.0% |
| 2015 FY | 3.07 Billion CNY | 12.25% |
| 2015 Q2 | 589.41 Million CNY | -21.02% |
| 2015 Q3 | 657.84 Million CNY | 11.61% |
| 2014 Q3 | 557.67 Million CNY | -1.87% |
| 2014 Q2 | 568.27 Million CNY | -16.1% |
| 2014 FY | 2.73 Billion CNY | 11.12% |
| 2014 Q4 | 932.88 Million CNY | 67.28% |
| 2014 Q1 | 677.32 Million CNY | -15.22% |
| 2013 Q3 | 567.69 Million CNY | -2.74% |
| 2013 Q1 | 512.18 Million CNY | -14.58% |
| 2013 FY | 2.46 Billion CNY | 42.02% |
| 2013 Q4 | 798.88 Million CNY | 40.72% |
| 2013 Q2 | 583.67 Million CNY | 13.96% |
| 2012 FY | 1.73 Billion CNY | 42.02% |
| 2012 Q4 | 599.57 Million CNY | 55.33% |
| 2012 Q2 | 318.22 Million CNY | -26.01% |
| 2012 Q1 | 430.11 Million CNY | 13.4% |
| 2012 Q3 | 386 Million CNY | 21.3% |
| 2011 Q1 | 287.64 Million CNY | -9.93% |
| 2011 FY | 1.22 Billion CNY | 26.09% |
| 2011 Q2 | 267.25 Million CNY | -7.09% |
| 2011 Q4 | 379.27 Million CNY | 32.28% |
| 2011 Q3 | 286.73 Million CNY | 7.29% |
| 2010 Q2 | 231.97 Million CNY | 13.51% |
| 2010 Q3 | 212.58 Million CNY | -8.36% |
| 2010 Q4 | 319.35 Million CNY | 50.22% |
| 2010 FY | 968.28 Million CNY | 10.93% |
| 2010 Q1 | 204.36 Million CNY | -14.49% |
| 2009 Q3 | 217.73 Million CNY | -12.8% |
| 2009 FY | 872.88 Million CNY | 16.52% |
| 2009 Q4 | 239 Million CNY | 9.77% |
| 2009 Q2 | 249.69 Million CNY | 50.01% |
| 2009 Q1 | 166.45 Million CNY | -14.09% |
| 2008 Q4 | 193.75 Million CNY | -3.39% |
| 2008 Q1 | 138.03 Million CNY | -13.14% |
| 2008 FY | 749.11 Million CNY | 14.56% |
| 2008 Q2 | 216.77 Million CNY | 57.05% |
| 2008 Q3 | 200.55 Million CNY | -7.48% |
| 2007 FY | 653.89 Million CNY | 20.39% |
| 2007 Q2 | 188.84 Million CNY | 34.4% |
| 2007 Q1 | 140.5 Million CNY | -12.35% |
| 2007 Q3 | 165.62 Million CNY | -12.29% |
| 2007 Q4 | 158.91 Million CNY | -4.06% |
| 2006 Q3 | 112.14 Million CNY | -35.32% |
| 2006 Q4 | 160.3 Million CNY | 42.94% |
| 2006 Q1 | 97.3 Million CNY | -27.06% |
| 2006 FY | 543.15 Million CNY | 5.44% |
| 2006 Q2 | 173.39 Million CNY | 78.19% |
| 2005 FY | 515.11 Million CNY | -6.73% |
| 2005 Q1 | 87.63 Million CNY | -41.13% |
| 2005 Q4 | 133.4 Million CNY | -8.85% |
| 2005 Q3 | 146.36 Million CNY | -0.91% |
| 2005 Q2 | 147.7 Million CNY | 68.55% |
| 2004 Q1 | 99.8 Million CNY | -58.57% |
| 2004 Q3 | 143.17 Million CNY | -10.76% |
| 2004 Q4 | 148.85 Million CNY | 3.97% |
| 2004 FY | 552.27 Million CNY | -4.92% |
| 2004 Q2 | 160.43 Million CNY | 60.76% |
| 2003 FY | 580.85 Million CNY | 1.97% |
| 2003 Q4 | 240.91 Million CNY | 69.94% |
| 2003 Q3 | 141.76 Million CNY | 33.83% |
| 2003 Q1 | 92.25 Million CNY | -54.96% |
| 2003 Q2 | 105.92 Million CNY | 14.82% |
| 2002 Q1 | 83.89 Million CNY | 0.0% |
| 2002 Q2 | 133.3 Million CNY | 58.9% |
| 2002 FY | 569.64 Million CNY | 45.85% |
| 2002 Q3 | 147.59 Million CNY | 10.72% |
| 2002 Q4 | 204.85 Million CNY | 38.8% |
| 2001 FY | 390.57 Million CNY | 85.72% |
| 2000 FY | 210.29 Million CNY | 61.04% |
| 1999 FY | 130.58 Million CNY | 0.0% |